Profile
| Role | Insider |
|---|---|
| Notability | 30/100 |
Board memberships
- INVO Fertility, Inc.
- Azitra, Inc.
- MiNK Therapeutics, Inc.
Updated Jul 16, 2026
Ryan Barbara has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — active on both sides. Lifetime open-market purchases: $1K. Lifetime open-market sales: $47K.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-05 | INKT | MiNK Therapeutics, Inc. | S — Open-market sale | 1.0K | $12.80 | $13K |
| 2026-06-05 | INKT | MiNK Therapeutics, Inc. | S — Open-market sale | 500 | $12.68 | $6K |
| 2026-06-02 | INKT | MiNK Therapeutics, Inc. | A — Grant or award | 1.4K | $12.38 | $18K |
| 2026-06-02 | INKT | MiNK Therapeutics, Inc. | A — Grant or award | 1.6K | $10.90 | $18K |
| 2026-05-14 | INDV | Indivior Pharmaceuticals, Inc. | A — Grant or award | 6.5K | $0.00 | |
| 2026-03-13 | INDV | Indivior Pharmaceuticals, Inc. | P — Open-market purchase | 8 | $31.09 | $249 |
| 2026-03-11 | INKT | MiNK Therapeutics, Inc. | S — Open-market sale | 500 | $15.30 | $8K |
| 2026-03-11 | INKT | MiNK Therapeutics, Inc. | S — Open-market sale | 500 | $15.57 | $8K |
| 2026-03-11 | INKT | MiNK Therapeutics, Inc. | S — Open-market sale | 300 | $15.28 | $5K |
| 2026-03-11 | INKT | MiNK Therapeutics, Inc. | S — Open-market sale | 200 | $10.17 | $2K |
| 2026-03-11 | INDV | Indivior Pharmaceuticals, Inc. | P — Open-market purchase | 31 | $32.56 | $1K |
| 2026-03-04 | INKT | MiNK Therapeutics, Inc. | S — Open-market sale | 100 | $10.83 | $1K |
| 2026-03-04 | INKT | MiNK Therapeutics, Inc. | S — Open-market sale | 400 | $10.86 | $4K |
| 2026-01-28 | INDV | Indivior Pharmaceuticals, Inc. | A — Grant or award | 3.7K | $0.00 | |
| 2025-12-03 | INKT | MiNK Therapeutics, Inc. | A — Grant or award | 1.6K | $11.09 | $18K |
| 2025-09-02 | INKT | MiNK Therapeutics, Inc. | A — Grant or award | 1.3K | $13.86 | $18K |
| 2024-12-03 | INKT | MiNK Therapeutics, Inc. | A — Grant or award | 24.2K | $0.73 | $18K |
Ryan Barbara is a corporate insider — currently tracked as Insider of MiNK Therapeutics, Inc. (INKT). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 2 open-market purchases ($1K) and 8 open-market sales ($47K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Ryan Barbara profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.